Rankings
▼
Calendar
AXGN Q2 2019 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena
AXGN
AxoGen, Inc.
$2B
Q2 2019 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$27M
+29.7% YoY
Gross Profit
$22M
84.1% margin
Operating Income
-$8M
-28.7% margin
Net Income
-$7M
-26.3% margin
EPS (Diluted)
$-0.18
QoQ Revenue Growth
+14.7%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$157M
Total Liabilities
$19M
Stockholders' Equity
$138M
Cash & Equivalents
$25M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$27M
$21M
+29.7%
Gross Profit
$22M
$17M
+28.5%
Operating Income
-$8M
-$5M
-59.2%
Net Income
-$7M
-$7M
+5.4%
← FY 2019
All Quarters
Q3 2019 →